SavedAdd your journal

Journals / Journal of Clinical and Analytical Medicine / 2014 / Cilt: 5 - Sayı: 4

Hemodiyaliz ve Periton Diyalizi Hastalarının Gastroskopik Bulgularının Arasında Fark var mıdır?

Is There Any Difference on Gastroscopic Findings Between Hemodialysis and Peritoneal Dialysis Patients?

Bülent YILDIZ
Sami FİDAN
Şükrü ULUSOY
Kübra KAYNAR
Mehmet ARSLAN
Gülsüm ÖZKAN
Safiye Tuba KAPLAN
Pages
280–282
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

H. pylori prevelance was also similar in both groups.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study is to compare retrospectively gastroscopic findingsof asymptomatic patients undergoing hemodialysis and peritoneal dialysis.Material and Method: Gastroscopic data of 101 patients with chronic renalfailure waiting kidney transplantation were evaluated in the current study.
📊
Key Findings & Data:Ofthe 101 patients, 77 were undergoing hemodialysis and 24 were undergoingperitoneal dialysis.
💡
Conclusion & Impact:H. pylori prevelance was also similar in both groups.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study is to compare retrospectively gastroscopic findingsof asymptomatic patients undergoing hemodialysis and peritoneal dialysis.Material and Method: Gastroscopic data of 101 patients with chronic renalfailure waiting kidney transplantation were evaluated in the current study. Ofthe 101 patients, 77 were undergoing hemodialysis and 24 were undergoingperitoneal dialysis. H. pylori status in patients with endoscopic findings wasevaluated by the rapid urease test. The demographic data and gastroscopicfindings of the patients were recorded. Results: Gastroscopic findings wereabnormal in 66.2% of hemodialysis group and 45.8% of peritoneal dialysisgroup. Gastritis was the most frequent finding in both groups. H. pylori rapidurease positivity was 31% and 54% of hemodialysis and peritoneal dialysisgroups, respectively. Discussion: No significant difference in gastroscopicfindings was observed between two groups of patients undergoing different dialysis modalities. H. pylori prevelance was also similar in both groups.

Özet

Amaç: Çalışmanın amacı asemptomatik hemodiyaliz ve periton diyalizi hastalarının gastroskopik bulgularını retrospektik olarak karşılaştırmaktır. Gereçve Yöntem: Çalışmada böbrek nakil listesinde beklemekte olan 101 kronikböbrek yetmezlikli hastanın gastroskopik verileri değerlendirildi. 101 hastanın 77sine hemodiyaliz ve 24üne periton diyalizi yapılmakta idi. Gastroskopik bulguları olan hastalarda Helikobakter pilori (HP)varlığı hızlı üreaz testi iledeğerlendirildi. Hastaların demografik verileri ve gastroskopik bulguları kaydedildi. Bulgular: Gastroskopide, hemodiyaliz hastalarında % 66,2, periton diyalizi hastalarında % 45,8 patolojik bulgu saptandı. Her iki grupta da en fazlagözlenen bulgu gastrit idi. HP hızlı üreaz tesi pozitifliği ise, sırasıyla iki grupta %31 ve % 54 olarak bulundu. Tartışma: Diyaliz modaliteleri farklı olan ikihasta grubumuzda gastroskopik bulgular açısından anlamlı fark yoktu. AyrıcaHP prevelansı da iki grupta benzerdi.

🔖

Cite This Article

YILDIZ, B., FİDAN, S., ULUSOY, Ş., KAYNAR, K., ARSLAN, M., ÖZKAN, G., KAPLAN, S. T. (2022). Hemodiyaliz ve Periton Diyalizi Hastalarının Gastroskopik Bulgularının Arasında Fark var mıdır?. Journal of Clinical and Analytical Medicine, Cilt: 5 - Sayı: 4, 280–282. https://ajindex.com/articles/561152

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Jain J, Thiele D. Gastrointestinal and hepatic manifestations of systemic diseases. In Feldman M, Friedman L, Brandt LJ. Eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease.8th ed. vol 1. Philadelphia, PA: Saunders Elsevier; 2006. p. 728
  2. Fabrizi F, Martin P, Dixit V, Quan S, Brezina M, Abbey H, et al. Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA H. pylori SIA. Nephrol Dial Transplant 1999;14(8):1929-33
  3. Cocchiara G, Romano M, Buscemi G, Maione C, Maniaci S, Romano G. Advantage of eradication therapy for Helicobacter pylori before kidney transplantation in uremic patients. Transplant Proc 2007;39(10):3041-3
  4. Khedmat H, Ahmadzad-Asl M, Amini M, Lessan-Pezeshki M, Einollahi B, Pourfarziani V et al. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients. Transplant Proc 2007;39(10):1003-7
  5. Abu Farsakh NA, Roweily E, Rababaa M, Butchoun R. Brief report: evaluation of the upper gastrointestinal tract in uraemic patients undergoing haemodialysis. Nephrol Dial Transplant 1996;11(5):847-50
  6. Altay M, Turgut F, Akay H, Kanbay M, Babali A, Akcay A, et al. Dyspepsia in Turkish patients on continuous ambulatory peritoneal dialysis. Int Urol Nephrol 2008;40(1):211-7
  7. Wee A, Kang JY, Ho MS, Choong HL, Wu AY, Sutherland IH. Gastroduodenal mucosa in uraemia: endoscopic and histological correlation and prevalence of Helicobacter-like organisms. Gut 1990;31(10):1093-6
  8. Sotoudehmanesh R, Ali Asgari A, Ansari R, Nouraie M. Endoscopic findings in end-stage renal disease. Endoscopy 2003;35(6):502-5
  9. Nakajima F, Sakaguchi M, Oka H, Kawase Y, Shibahara N, Inoue T et al. Prevalence of Helicobacter pylori antibodies in long-term dialysis patients. Nephrology (Carlton) 2004;9(2):73-6
  10. Yucel T, Aygin D, Sen S, Yucel O. The prevalence of Helicobacter pylori and related factors among university students in Turkey. Jpn J Infect Dis 2008;61(3):179-83
  11. Ozden A, Bozdayi G, Ozkan M, Köse KS. Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years. Turk J Gastroenterol 2004;15(3):156-8
  12. Ozgür O, Boyacioğlu S, Ozdoğan M, Gür G, Telatar H, Haberal M. Helicobacter pylori infection in haemodialysis patients and renal transplant recipients. Nephrol Dial Transplant 1997;12(2):289-91.